NCT02666209 2017-08-28
Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma
Dana-Farber Cancer Institute
No longer available
Dana-Farber Cancer Institute
Janssen-Ortho Inc., Canada
Millennium Pharmaceuticals, Inc.